Resources

1 Resources for

sibutramine

FDA Moves Against Unapproved Obesity Drugs: The FDA has published a list of unapproved, "tainted," or "undeclared" weight-loss drugs that it wants off the market. The list includes rimonabant and sibutramine. Rimonabant was the active ingredient in Zimulti/Acomplia, the ill-fated obesity treatment that Sanofi-Aventis tried to get approved in the U.S. The FDA turned the application...; Tags: FDA, Pill, Sibutramine, Meridia, Vivus, Federal Government, Government, Jim Edwards; Blog posts 2009-01-09

Abbott Laboratories is working with Italian and European authorities to confirm the safety of Meridia/Reductil (sibutramine). (Active Pharmaceutical Ingredient Watch).(Brief Article): ABBOTT Laboratories is working with Italian and European authorities to confirm the safety of Meridia/Reductil sibutramine. Italy has suspended the sale of ... ABBOTT Laboratories is working with Italian and European authorities to confirm the safety of Meridia/Reductil sibutramine. Italy has suspended the...; Tags: Abbott Laboratories Inc.; Research articles 2002-03-18
FDA watches Meridia reports after deaths in Italy: The FDA said in March that it is monitoring Abbott Laboratories' European adverse event reports involving the use of weight-loss drug Meridia sibutramine, which is called Reductil overseas, following temporary marketing suspension ordered by the Italian Health Ministry, reportedly because two patients died after taking the medication. In addition, Italian...; Tags: FDA; Research articles 2002-05-01
FDA delays action on Meridia petition: The FDA has delayed taking any action on a petition seeking the withdrawal of Abbott Laboratories' weight-loss drug Meridia sibutramine on safety grounds. The FDA's director of drugs, Janet Woodcock, recently wrote Public Citizen Health Research Group Director Sidney Wolfe informing him that the agency had not yet completed its...; Tags: FDA, petition; Research articles 2002-12-01